Executives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.

The debate in Washington over drug pricing is getting louder and nastier, and drug marketing is getting caught in the crossfire.

With presidential primaries right around the corner, the cost of prescription drugs is at the top of the public’s healthcare priority list for the President and Congress, according to polling data from the Kaiser Family Foundation.

The antitrust division of the U.S. Department of Justice has subpoenaed Mylan N.V. for information relating to the marketing, pricing and sale of its generic doxycycline antibiotic products, the drugmaker said on Friday. The Department of Justice has sought information on any communication with competitors about the anti-bacterial products, the company said in a regulatory […]

After five years of failed attempts, U.S. Senate Republicans on Thursday passed a symbolic partisan bill to gut President Barack Obama’s signature healthcare reform law, but the effort has already been condemned to death by Obama’s plans to veto it.   The Republican-controlled Senate voted 52-47 to repeal several core Obamacare provisions under special budget […]

U.S. state Medicaid programs spent $1.3 billion before rebates in 2014 on Gilead Sciences’ new hepatitis C drugs to treat fewer than 2.4 percent of enrollees with the liver disease, according to a U.S. Senate investigation into pricing of the blockbuster medicines. In the latest salvo against high U.S. prices for important medicines, the 18-month […]

(And a way to save some drug companies from themselves) November 25, 2015 By Karl Thiel for BioSpace.com   Price gouging in the pharmaceutical industry has been much in the news lately. There was, of course, the recent case of Turing Pharma and its 5,400 percent increase on the price on Daraprim, a decades-old drug. […]

Drug companies have brought a host of expensive new medicines to market in the United States and Europe this year, figures show, another bumper haul for an industry often accused of over-charging. Drug prices are set to be a major issue in the run-up to the U.S. presidential election next year, with Democratic candidate Hillary […]

The American Medical Association on Tuesday called for a ban on advertising prescription drugs and medical devices directly to consumers, saying the ads drive patients to demand expensive treatments over less costly ones that are also effective. The influential doctors’ group said the new policy reflects physicians’ concerns that marketing spending on a proliferation of […]

A Roche drug that can prolong the lives of some women with advanced breast cancer has been plunged back into the center of a drug pricing row after Britain’s health cost agency declared that it is still too expensive. The stand-off shows how the price of medicines is as pressing and emotive an issue in […]